Orimoloye, Olusola Ayodeji

Electrocardiographic Manifestations of Immune Checkpoint Inhibitor Myocarditis

Power, J. R., Alexandre, J., Choudhary, A., Ozbay, B., Hayek, S., Asnani, A., Tamura, Y., Aras, M., Cautela, J., Thuny, F., et al. (2021) · Circulation

Cancer Immunotherapy and BiomarkersViral Infections and Immunology Research

Cited by 136

Long-Term All-Cause and Cause-Specific Mortality in Asymptomatic Patients With CAC ≥1,000

Peng, A. W., Mirbolouk, M., Orimoloye, O. A., Osei, A. D., Dardari, Z., Dzaye, O., Budoff, M. J., Shaw, L., Miedema, M. D., Rumberger, J., et al. (2020) · JACC: Cardiovascular Imaging

Cardiac Imaging and DiagnosticsHealthcare Systems and Public Health

Cited by 134

E-Cigarette Use Patterns and High-Risk Behaviors in Pregnancy: Behavioral Risk Factor Surveillance System, 2016–2018

Obisesan, O. H., Osei, A. D., Uddin, S. M. I., Dzaye, O., Cainzos-Achirica, M., Mirbolouk, M., Orimoloye, O. A., Sharma, G., Al Rifai, M., Stokes, A., et al. (2020) · American Journal of Preventive Medicine

Smoking Behavior and CessationPrenatal Substance Exposure Effects

Cited by 70

Association of early electrical changes with cardiovascular outcomes in immune checkpoint inhibitor myocarditis

Power, J. R., Alexandre, J., Choudhary, A., Ozbay, B., Hayek, S. S., Asnani, A., Tamura, Y., Aras, M., Cautela, J., Thuny, F., et al. (2022) · Archives of Cardiovascular Diseases

Viral Infections and Immunology ResearchCancer Immunotherapy and Biomarkers

Cited by 43